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Surveillance  networks  for rotavirus  document  the burden  of  the  disease  using  the  proportion  of  chil-
dren  hospitalized  with  gastroenteritis  positive  for  rotavirus  by enzyme  immunoassay.  They  also  describe
genotypes  of circulating  viruses  by polymerase  chain  reaction  for  the  VP7  and  VP4  genes,  which  deter-
mine  G  and  P types,  respectively.  A  proportion  of  samples  cannot  be genotyped  based  on  initial  testing
and  laboratories  need  to  assess  further  testing  strategies  based  on  resources  and  feasibility.  To 365  sam-
ples obtained  from  an  Indian  rotavirus  strain  surveillance  program,  we  applied  an approach  to  determine
the  G and  P types  in  antigen  positive  samples  that failed  to type  initially  with  the  standard  laboratory
protocol.  Fifty-eight  samples  (19%)  were  negative  for the  VP6  gene,  indicating  that  the antigen  test  was
likely  to have  been  false  positive.  Alternative  extraction  and  priming  approaches  resulted  in the  identi-
ﬁcation  of  G and  P  types  for 264  strains.  The  identity  of one  strain  was  determined  by sequencing  the
ﬁrst-round  amplicons.  Thirty-ﬁve  strains  were  partially  typed  and  seven  strains  could  not  be  typed  at  all.
The distribution  of G  and  P types  among  strains  that  had initially  failed  to type,  except  one  strain,  did  not
differ  from  that  in  strains  that  were typed  using  the  standard  laboratory  protocol.
d  by ©  2014  Publishe
. Introduction
Rotaviruses are an important cause of acute diarrhea in both
umans and animals. The genus rotavirus belongs to the family
eoviridae and is further classiﬁed by three different speciﬁcities:
roup, subgroup and serotypes. Rotaviruses are classiﬁed based
n the VP6 protein into seven groups (A–G) [1]. Of these, Group
 rotaviruses are an important cause of mortality and morbid-
ty in children <5 years of age, especially in the developing world
2]. Group A rotaviruses are further classiﬁed into subgroupsbased
n the VP6 proteins and into G and P sero-/genotypes based on
wo outer capsid proteins VP7 and VP4, respectively. Currently
here are 27 G and 37 P genotypes characterized [3]. A wide vari-
ty of rotavirus types circulate in humans and animals. Rotavirus
iversity is generated through three main mechanisms: mutation,
eassortment and inter-species transmission [4,5].
 The ﬁndings and conclusions in this report are those of the authors and do not
ecessarily represent the ofﬁcial position of the Centers for Disease Control and
revention.
∗ Corresponding author at: Division of Gastrointestinal Sciences, Christian Medical
ollege, Vellore, TN 632004, India. Tel.: +91 416 228 2052.
E-mail address: sudhirbabji79@cmcvellore.ac.in (S. Babji).
ttp://dx.doi.org/10.1016/j.vaccine.2014.04.024
264-410X/© 2014 Published by Elsevier Ltd. This is an open access article under the CC Elsevier  Ltd.  This is an  open  access  article  under  the  CC  BY-NC-ND  license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Most surveillance networks now use polymerase chain reaction
(PCR)-based approaches to determine VP7 (glycoprotein, G-) and
VP4 (protease sensitive protein, P-) genotypes. These networks,
largely coordinated by the World Health Organization (WHO) since
2008, have shown that there is a wide geographic and temporal
diversity in circulating G and P types identiﬁed from children less
than 5 years of age hospitalized with acute gastroenteritis, in whom
rotavirus is detected by an enzyme immunoassay across the differ-
ent regions of the world reporting as part of the WHO  rotavirus
surveillance network [6]. The understanding of genotype distribu-
tion has shown that two  widely used vaccines appear to protect
against homologous and heterologous viruses. But the long term
effects on virus circulation exerted by the immune pressure of a
vaccinated population are as yet unknown and warrant continued
molecular surveillance at this time. Additionally, studies on virus
diversity and evolution are important to understand the biology
of transmission and circulation in the population. This knowledge
propels the application of robust molecular methods to identify the
prevalent genotypes and methods to track the emergence of novel
viruses.
A WHO  manual describes the methods used to perform initial
identiﬁcation and further characterize group A rotavirus isolates
[7]. Although the methods and primer sets described in the manual
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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nd by other networks appear to identify the majority of strains
ased on updated WHO  reports and network publications [6,8,9],
 proportion of strains remain untyped and require further test-
ng. As the referral laboratory for the Indian National Rotavirus
urveillance Network which collected >4000 stool samples from
1 hospitals in 4 regional centers [8,11], we have developed an
pproach to handling samples initially untyped by standard meth-
ds and describe its application to samples collected over ﬁve years
rom 2007 to 2012.
. Materials and methods
.1. Samples
Stool samples were received for VP7 and VP4 molecular char-
cterization in the Wellcome Trust Research laboratory (WTRL)
rom 2007 to 2012, as part of the Indian Rotavirus Strain Surveil-
ance Network (IRSSN) or as referrals. All samples were screened by
nzyme immunoassay (Premier Rotaclone, Meridian Diagnostics,
incinnati, OH) and the antigen positive samples were geno-
yped as previously described elsewhere [8]. Complementary DNA
cDNA) was synthesized by reverse transcription (RT) as previously
escribed using random primers (Pd(N)6 hexamers; Pharmacia
iotech) and 400 units of Moloney murine leukemia virus reverse
ranscriptase (Invitrogen Life Technologies) [8]. Brieﬂy, a ﬁrst-
ound RT-PCR targeting VP7 and VP4 consensus regions using
rimers (VP7F/R and Con3/Con2, respectively) described in Table 1
ere performed. The ﬁrst-round product was used as a template
o determine speciﬁc VP7 (G) types (G1, G2, G3, G4, G8, G9, G10
nd G12) and VP4 (P) types (P[4], P[6], P[8], P[9], P[10], P[11])
n a semi-nested multiplex PCR format [8]. Of the 2226 rotavirus
LISA positive samples for which further molecular characteriza-
ion was performed, 57 samples were partially genotyped and 308
amples were untyped for G and P types. These represent 2.5% par-
ially genotyped and 13.5% completely untyped samples of the total
amples forwarded for further analysis.
.1.1. Approach to completely untyped samples
RNA was re-extracted from 30% fecal suspensions using the
IAamp Viral Mini RNA kit (Qiagen, Hilden, Germany) as per the
anufacturer’s speciﬁcations for samples collected from 2007 to
009 that were initially extracted using Trizol reagent (Invitro-
en Life Technologies). Samples collected from 2010 to 2012 were
nitially subjected to RNA extraction using the Viral Mini RNA kit
ethod; re-extraction was performed using the Trizol reagent.
Polymerase chain reaction amplifying the VP6 region was
erformed to determine the presence or absence of rotavirus using
able 1
P6, VP7 and VP4 primers used in this study [7].
VP6 primers
VP6-F GACGGVGCRACTACATGGT nt 747–766
VP6-R GTCCAATTCATNCCTGGTGG nt 1126–1106
VP7 consensus primers
Primers used in the standard protocol
VP7-F ATG TAT GGT ATT GAA TAT ACC AC nt 51–71
VP7-R AAC TTG CCA CCA TTT TTT CC nt 914–932
Alternate consensus VP7 primers
9con1-L TAG CTC CTT TTA ATG TAT GGT AT nt 37–59
VP7-R AAC TTG CCA CCA TTT TTT CC nt 914–933
VP4 consensus primers
Primers used in the standard protocol
Con3 TGG CTT CGC TCA TTT ATA GAC A nt 11–32
Con2 ATT TCG GAC CAT TTA TAA CC nt 868–887
Alternate consensus VP4 primers
VP4-F TAT GCT CCA GTN AAT TGG nt 132–149
VP4-R ATT GCA TTT CTT TCC ATA ATG nt 775–795S (2014) A84–A88 A85
primers described in Table 1 and random primed cDNA [10]. For
samples that were negative for the VP6 gene by PCR with random
primed cDNA, cDNA was synthesized using speciﬁc priming and
ampliﬁed with the VP6 primers using the OneStep RT-PCR kit
(Qiagen, Hilden, Germany). Samples that were negative by this
method were recorded as negative on VP6 PCR with false positive
ELISA. The samples positive for the VP6 gene were subjected
to G and P typing using the standard primer sets as previously
described [11].
2.1.2. Approach to partially typed samples and VP6 PCR positive
samples
RNA from samples which were partially typed and VP6 PCR
positive samples which remained untyped after re-extraction and
application of the standard genotyping protocol were subjected to
speciﬁc priming for reverse transcription and ampliﬁcation using
the VP7F/R and Con2/Con3 primers and the One Step RT-PCR kit
(Qiagen, Hilden, Germany), followed by a second-round PCR with
the standard primer set. Typing of samples that remained untyped
was attempted using alternate primer sets targeting the consen-
sus regions of the VP7 and VP4 genes (Table 1) [7]. If present, the
ﬁrst-round product was  sequenced for strains that were still G and
P untyped (Fig. 1).
2.2. Sequencing
Sequencing of the ﬁrst-round amplicon was attempted for all
VP6 positive, G- and P-untyped samples. Brieﬂy, the amplicons
were puriﬁed and sequenced in both directions with the ABI PRISM
Big Dye Terminator Cycle Sequencing Ready Reaction Kit (Applied
Biosystems, Foster City, CA) using the same primer pairs as in the
ﬁrst-round PCR. The sequences were resolved in the automated
DNA sequencer, the ABI PRISM 310 Genetic Analyzer (Applied
Biosystems), and the electropherograms were analyzed using
sequencing analysis software (Finch TV, version 1.4.0). Consensus
sequences were compared with available rotavirus sequences in
GenBank for genotype conﬁrmation using the Basic Local Align-
ment Search Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
3. Results
We explored an approach (Fig. 1) to further characterize par-
tially and completely untyped samples for G and P typing of 57
partially typed and 308 untyped samples. Fifty-eight (58/308, 19%)
of the untyped samples were negative for VP6 gene ampliﬁcation
after repeat extraction and VP6 PCR using both random and speciﬁc
priming methods. These were considered ELISA false positives.
Of the 250 samples that were VP6 positive, we  determined both
G and P genotypes for 211 samples following re-extraction, reverse
transcription (RT) using random hexamer priming and genotyping
with the standard protocol. Inclusion of the remaining 39 untyped
samples and 57 partially typed samples for reverse transcription
and ampliﬁcation with the One Step RT-PCR, using speciﬁc priming
for VP7 and VP4, resulted in resolution of both G and P genotypes
for an additional 45 samples. We  subjected the remaining par-
tially typed and untyped samples (n = 51) to speciﬁc priming for
VP7 and VP4 RT using alternate primer sets (Table 1). This led to
determination of both G and P types for 8 strains and partial typ-
ing for 35 strains (12 G untyped and 23 P untyped). Seven samples
remained completely untyped (Fig. 2). Of the original 57 partially
typed samples, 22 remained partially typed.
Only one sample which failed to type in the second-round PCR
for either VP7 or VP4 had a ﬁrst round product for both genes and
these were sequenced and the strain identiﬁed as G11P[25].
The most common G and P types isolated were G1 (n = 100/307,
32%) and P[8] (n = 157/307, 51%), respectively (Table 2).
A86 S. Babji et al. / Vaccine 32S (2014) A84–A88
ained 
4
3
5
a
GFig. 1. Testing strategy for untyped rotavirus ELISA positive samples obt
. Discussion
Use of a standard protocol for genotyping had resulted in
08/2226 (13.5%) samples being untyped for G and P types and
7/2226 (2.5%) being partially typed for either G or P type. The
pproach we used, as shown in Fig. 1, is to sequence the ﬁrst-round
 and P ampliﬁcation product, if available. If not present, the
Fig. 2. Number of rotavirus strains typed by the from the Indian Rotavirus Strain Surveillance Network sites, 2007–2012.
presence of rotavirus is conﬁrmed by performing VP6 PCR using
both random and speciﬁc priming approaches after re-extraction.
If VP6 is positive, speciﬁc priming with standard G and P primers
or alternate primer sets was  carried out to attempt genotyping of
these samples.
Application of the VP6 PCR for conﬁrmation resulted in the iden-
tiﬁcation of 58/2226 (2.6%) false positive ELISA results. A recent
approach to genotyping used in this study.
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Table  2
Combination of G and P types of rotavirus strains obtained by following the approach to typing of initially untypable samples obtained from the Indian surveillance network,
2007–2012. Note that there was no circulation of G3 and G4 strains at the surveillance sites during this period.
P[4] P[6] P[8] Other P types P Untyped Mixed P types Total
G1 12 0 73 0 12 3 100
G2  68 0 0 0 2 0 70
G9  8 0 48 11 7 0 74
G12  0 10 28 0 2 0 40
Other  G types 0 0 0 1 0 0 1
G  Untyped 4 0 8 0 7 0 19
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ublication has indicated the sensitivity and speciﬁcity of the Pre-
ier Rotaclone kit to be 76% and 100%, respectively [12]. It is
ossible that the ELISA false positives identiﬁed in this study could
e due to degradation of the nucleic acid in the samples, but it
ould also be due to variation in test performance characteristics
epending on the laboratory and the types of samples included for
valuation.
In the remaining 307 untyped and partially typed samples, alter-
ate extraction methods with the standard primer sets resulted in
yping of both G and P types in 256 (83%) and partially typing in 43
14%) samples. Hence, use of the standard primer sets resulted in
 or P or both types in 97% of the samples obtained from India. The
ack of initial typing may  be because of the inefﬁciency of the extrac-
ion followed by random priming or because PCR inhibitors may
e carried over from extraction. A comparison of various available
ommercial manual and automated extraction methods reported
hat the QIAmp Viral Mini RNA kit may  carry over RT-PCR inhibitors
13], which may  have resulted in the lack of initial genotyping. The
urveillance network uses Trizol or kit based extraction and a ran-
om priming approach for cDNA generation, because both G- and
-typing PCRs can then be set up using the same cDNA.
However, other kits, particularly the automated extraction
ethods and one-step RT-PCR kits, are expensive to use for the
arge numbers of samples in a surveillance program. Laborato-
ies need to allocate resources for initial screening and genotyping
ollowed by further characterization based on the level of detail
ecessary to meet surveillance objectives.
One inexpensive approach for controlling problems with extrac-
ion is to spike all samples with a non-competing internal control
NA virus to check for the efﬁciency of the extraction procedure
erformed, where PCR ampliﬁcation for the control virus can be
erformed either along with the typing PCR or separately in sam-
les that fail to genotype.
The use of additional primer sets typed an additional eight
trains for both G and P types. Seven samples remained untyped and
5 were partially typed respectively after using additional primers
14]. Only for one sample from Delhi, sequencing of the ﬁrst-round
roduct led to the identiﬁcation of G11P[25], a type previously
eported infrequently from India and Bangladesh [15]. No new
enotypes were isolated and the predominant G and P types iden-
iﬁed were G1 and P[8], which were reﬂective of the types isolated
reviously from the various locations.
Using the approach detailed above, the number of samples
ully or partially typed increased from 86% (1918/2226) to 97%
2161/2226). This approach shows that if a robust set of standard
rimers are available that genotype the bulk of specimens in
nitial testing, the unresolved genotypes are likely to be false pos-
tive ELISA samples or those which have had a problem with
he efﬁciency of extraction. The use of additional primer sets
esolves genotypes only in a very small fraction of the samples.
nlike in 2007, when an increase in the number of G-untyped
trains resulted in the identiﬁcation of a new genotype, G12, by
equencing of the ﬁrst-round product [16], no new genotypes were
[0 1 3
30 4
detected in multiple untyped samples from the network. Future
approaches to genotyping for untypable samples might also include
next-generation sequencing, which has not been used for ﬁeld
surveillance so far.
While documenting genotypes has been a mainstay of rotavirus
epidemiology in the past, the data emerging from the oral rotavirus
vaccines indicate that real-time knowledge of genotypes may  not
be necessary to inform understanding of response to and protec-
tion afforded by vaccines. Since vaccines have only been in use
for a few years and in limited geographic settings, it is possible
that continued surveillance will provide data suitable for long term
surveillance. Therefore, laboratories and networks need to decide
the extent to which they will pursue genotyping of rotavirus strains
and allocate appropriate resources.
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